Picture of ehave logo

EHVVF ehave Share Price

0.000.00%
us flag iconLast trade - 00:00
TechnologyHighly SpeculativeMicro Cap

Momentum

Relative Strength (%)
1m-17.76%
3m-45.34%
6m+70.45%
1yr+57.64%
Volume Change (%)
10d/3m-64.3%
Price vs... (%)
52w High-82.11%
50d MA-32.22%
200d MA+0.29%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of ehave EPS forecast chart

Profile Summary

Ehave, Inc. is a Canada-based company, which is engaged in creating a medical psychedelic and mental health data platform that integrates with its proprietary and third-party assessment and therapeutic digital applications. The Company’s product focus is based on two tiers of activities: MegaTeam and Ninja Reflex, its clinically validated digital assessment and rehabilitation software that is engaging for the patient, and adaptation of custom and third-party clinically validated digital assessment and rehabilitation software for enhanced patient engagement and data modeling. The Company also intends to provide technology solutions to clinicians, patients, researchers, pharmaceutical companies and payers. Additionally, through its KetaDash subsidiary, the Company provides a platform for medical practitioners to administer healthcare services to patients at home, with an emphasis on providing ketamine infusion services.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2021
Incorporated
October 31st, 2011
Public Since
November 14th, 2016
No. of Shareholders
59
Sector
Software & IT Services
Industry
Technology
Exchange
us flag iconPink Sheets on Nasdaq
Shares in Issue
359,571,047

EHVVF Share Price Performance

Upcoming Events for EHVVF

Similar to EHVVF

Picture of 1606 logo

1606

us flag iconPink Sheets on Nasdaq

Picture of Ablaze Technologies logo

Ablaze Technologies

us flag iconPink Sheets on Nasdaq

Picture of Acorn Energy logo

Acorn Energy

us flag iconPink Sheets on Nasdaq

Picture of Advantego logo

Advantego

us flag iconPink Sheets on Nasdaq

FAQ